National and Kapodistrian University of Athens
Μελέτη μοριακών δεικτών σε ασθενείς με προδιηθητικές αλλοιώσεις του μαστού σε υλικό ελάχιστα επεμβατικής βιοψίας
Abstract
dc:descriptionBACKGROUND: Elevated Hsp90 expression has been documented in breast ductal carcinomas. The purpose of this study was to examine the immunohistochemical expression of Hsp90 all along the continuum of breast ductal lesions encompassing atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS), and invasive ductal carcinoma (IDC). Moreover, this is the first study to focus on the continuum of breast lobular lesions, going beyond lobular neolplasia (LN) and assessing Hsp90 expression in infiltrative lobular carcinomas (ILC). Especially, in LN we tried to examine whether Hsp90 expression is associated with estrogen receptor alpha (ERalpha) and beta (ER-beta) immunostaining. METHODS: Tissue specimens were taken from 65 patients with LN, 32 patients with ILC, 31 patients with ADH, 51 with DCIS and 51 with IDC. Immunohistochemical assessment of Hsp90 was performed both in the lesion and the adjacent normal breast ducts and lobules; the latter serving as control. In the first 44 patients with LN immunohistochemical assessment of ERalpha and ER-beta was performed. Concerning Hsp90 assessment: i) the percentage of positive cells and ii) the intensity was separately analyzed. Subsequently, the Allred score was adopted and calculated. The intensity was treated as an ordinal variablescore (0: negative, low: 1, moderate: 2, high: 3). Statistical analysis followed. Post hoc analysis on the correlations between Hsp90 Allred score and possible predictors (grade, nodal status, diameter, ER Allred score, PR Allred score, c-erbB2 status and triple negative status) was conducted. RESULTS: Hsp90 exhibited mainly cytoplasmic immunoreactivity; some epithelial cells also showed nuclear staining. Compared to the adjacent normal ducts and lobules, no statistically significant differences were noted in ADH and DCIS. Hsp90 expression (intensity, positive cells, Allred score) was higher in IDC, compared to the adjacent normal tissue. Higher Hsp90 expression was observed in grade 2/3 IDCs (borderline association) and larger diameter. At the univariable analysis, higher Hsp90 expression was associated with higher ER Allred score, PR Allred score and c-erbB2 positivity. Triple-negative IDCs exhibited significantly lower Hsp90 expression. The multivariable logistic regression model revealed that between the three markers, solely ER Allred score and c-erbB2 positivity were independently associated with higher Hsp90 expression. Compared to the adjacent normal ducts and lobules, LN cases exhibited lower Hsp90 intensity and lower Hsp90 Allred score at a marginally significant level, but no statistically significant change was noted concerning Hsp90-positive cells (%).Within the LN foci, the Hsp90 Allred score was neither associated with ER-alpha, nor with ER-beta percentage. With regard to ILC, a statistically significant decrease in Hsp90 expression, both in terms of positive cells(%) and Allred score, was noted (74.2±11.2 vs. 59.1±14.2 p=0.0001; 7.00±0.95 vs. 6.22±1.01, p=0.007, Wilcoxon matched-pairs signed-ranks test). CONCLUSION: The above point to significant variability in Hsp90 expression with significant implications upon the effectiveness and limitations of anti-Hsp90 drugs. It seems that the distinction of breast carcinomas to ductal and lobular is out of question correct; proving that each category may has its own etiology, progression and potentially different treatment.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Zagouri, Flora
- Ζαγουρή, Φλώρα
Subjects
dc:subject × 21- Μαστός
- Προδιθηθτικές αλλοιώσεις
- Ελάχιστα επεμβατική βιοψία
- Πρωτεΐνη θερμικού σοκ 90
- Οιστρογονικός υποδοχέας βήτα
- Λοβιακή νεοπλασία
- Καρκίνος
- Άτυπη επιθηλιακή υπερπλασία
- Breast
- Preinvasive lesions
- Minimally invasive biopsy
- Heat shock protein 90
- Hsp90
- Oestrogen receptor - b
- Lobular neoplasia
- Cancer
- Atypical ductal hyperplasia
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24312